Fox Run Management’s Pediatrix Medical MD Stock Holding History

Fox Run Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$758K	Buy	+29,921	New	+$681K	0.13%	297
2025 Q2	–	Sell	-23,783	Closed	-$345K	–	1071
2025 Q1	$345K	Buy	+23,783	New	+$338K	0.05%	628
2023 Q3	–	Sell	-15,584	Closed	-$221K	–	870
2023 Q2	$221K	Buy	+15,584	New	+$219K	0.06%	551
2021 Q3	–	Sell	-9,607	Closed	-$290K	–	565
2021 Q2	$290K	Buy	+9,607	New	+$284K	0.26%	173
2020 Q1	–	Sell	-11,379	Closed	-$316K	–	271
2019 Q4	$316K	Buy	+11,379	New	+$285K	0.25%	176
2019 Q2	–	Sell	-14,137	Closed	-$384K	–	547
2019 Q1	$384K	Sell	14,137 -246	-2%	-$8.25K	0.22%	181
2018 Q4	$475K	Sell	14,383 -2,252	-14%	-$90.5K	0.25%	125
2018 Q3	$776K	Buy	+16,635	New	+$764K	0.34%	39
2018 Q1	–	Sell	-12,060	Closed	-$644K	–	839
2017 Q4	$644K	Sell	12,060 -1,340	-10%	-$63.2K	0.19%	192
2017 Q3	$578K	Buy	+13,400	New	+$637K	0.16%	239

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Fox Run Management's MD Position: Q2 2026 in Review

Fox Run Management opened a new position in Pediatrix Medical (MD) in Q2 2026: 29,921 shares worth $758K. The stake represents 0.13% of the portfolio and ranks #297 among its holdings. This is a return to the name: Fox Run Management previously reported a position in MD as recently as Q1 2025.

Fox Run Management first reported a position in MD in Q3 2017 and has held it in 10 quarters since. The position peaked at $776K in Q3 2018. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Fox Run Management held 29,921 shares of Pediatrix Medical worth $758K as of Q2 2026.
Pediatrix Medical was a new Fox Run Management position in Q2 2026.
Pediatrix Medical made up 0.13% of Fox Run Management's portfolio in Q2 2026, its #297 holding.
Fox Run Management first reported a position in Pediatrix Medical in Q3 2017 and has held it in 10 quarters since.
Fox Run Management's Pediatrix Medical position peaked at $776K in Q3 2018.
305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.